NHS National Framework for Generics Housekeeping
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £52,023,284 (£62,427,941 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 8 Oct 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-058823 |
Awards (50)
This procurement was awarded to 41 suppliers. Values shown are per-award; the notice total is £52,023,284.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord UK Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Accord UK Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Alissa Healthcare Research Limited shared | £17,843,324 | 10 Nov 2025 | active |
| Amarox Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Baxter Healthcare Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Biocon shared | £21,562,716 | 10 Nov 2025 | active |
| Brown & Burk UK Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Chiesi Limited shared | £17,843,324 | 10 Nov 2025 | active |
| Cipla (EU) Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Crescent Pharma Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Day Lewis Medical Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Dr. Reddy's Laboratories (UK) Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Drugsrus Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Drugsrus Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Grindeks Kalceks UK Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| hameln pharma ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Hikma Pharmaceuticals shared | £21,562,716 | 10 Nov 2025 | active |
| Infectopharm Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| JCSH Pharma Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Kent Pharma Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Kent Pharma Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Luye Pharma Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Martindale Pharma shared | £21,562,716 | 10 Nov 2025 | active |
| Martindale Pharma shared | £17,843,324 | 10 Nov 2025 | active |
| Medreich PLC shared | £17,843,324 | 10 Nov 2025 | active |
| Mercury Pharmaceuticals Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Mercury Pharmaceuticals Limited shared | £17,843,324 | 10 Nov 2025 | active |
| Milpharm Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Milpharm Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Morningside Pharmaceuticals shared | £17,843,324 | 10 Nov 2025 | active |
| Necessity Supplies Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Novartis Pharmaceuticals UK Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Novumgen Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Pfizer Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Pfizer Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Pfizer Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Relonchem Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Rosemont Pharmaceuticals Limited shared | £17,843,324 | 10 Nov 2025 | active |
| RPH Pharmaceuticals AB shared | £21,562,716 | 10 Nov 2025 | active |
| Seacross Pharmaceuticals Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Sun Pharma UK Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Teva UK Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Teva UK Limited shared | £17,843,324 | 10 Nov 2025 | active |
| Thornton and Ross Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Tillomed Laboratories Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Viatris UK Healthcare Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Wockhardt UK Limited shared | £21,562,716 | 10 Nov 2025 | active |
| Zentiva Pharma UK Ltd shared | £21,562,716 | 10 Nov 2025 | active |
| Zentiva Pharma UK Ltd shared | £17,843,324 | 10 Nov 2025 | active |
| Zydus Pharmaceuticals UK Ltd shared | £21,562,716 | 10 Nov 2025 | active |
description
NHS National Framework for Generics Housekeeping
Offer reference number: CM/PHG/25/5733
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/25/5733/01 Oral products
CESW/LSNE/NWLN 01/02/2026 to 31/05/2027 (16 months)
CM/PHG/25/5733/02 Hospital only products
DCE/DSW 01/02/2026 to 30/09/2027 (20 months)
DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)
DLN/DNW 01/02/2026 to 31/01/2027 (12 months)
documents
- https://www.find-tender.service.gov.uk/Notice/052897-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/055086-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/059922-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4667 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4990 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-5598 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
6 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 14 Aug 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 048846-2025 |
| 1 Sept 2025 | Tender notice (UK4) | Procurement Act 2023 | 052897-2025 |
| 9 Sept 2025 | Tender notice (UK4) | Procurement Act 2023 | 055086-2025 |
| 26 Sept 2025 | Tender notice (UK4) | Procurement Act 2023 | 059922-2025 |
| 11 Nov 2025 | Contract award (UK6) | Procurement Act 2023 | 072699-2025 |
| 22 Dec 2025 | Contract details (UK7) | Procurement Act 2023 | 085542-2025 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.